Amoéba Logo


ISIN: FR0011051598 | Ticker: ALMIB
Sector: MaterialsSub-Industry: Specialty Chemicals
Country: France

About Amoéba

Company Description

Created in July 2010, Amoéba is an innovative company whose initial objective was to develop a patent from the University of Lyon. This patent is based on a unique micro-organism, the amoeba Willaertia magna C2c Maky, which is able to fight against the proliferation of legionella.

Amoéba has been able to develop its scientific, industrial and commercial expertise around the amoeba. We are now able to offer technological solutions and products for different applications and industries.

Amoeba has developed two technologies.
The first one is used for the treatment of water, surfaces and chronic wounds and uses for that the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky.
The second technology is dedicated to agriculture and more precisely to biocontrol for the treatment of phytopathogenic microorganisms using the lysed (non-living) form of this same amoeba.

Year founded


Served area



38 Avenue des Frères Mongolfier, 69680 Chassieu – France

Filings & Publications

Sign up and we will give you access!

Insider Trades

Date Trading entity / Person Association Trade type Volume
17.01.24 None Other Sell EUR 1,828.97

Capital markets information





Industry Group





Specialty Chemicals

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.